Electra Ltd ELTR

Electra has delivered a solid share price run over the past few years, which naturally raises the question of whether the current tag is fully supported by its earnings. With the stock now around ₪114.2, investors are asking how much of that strength can be explained by the underlying profit engine rather than sentiment alone. Electra has returned about 60.8% over the past 3 years, which puts real weight on the question of whether its earnings now justify the higher starting point for new...

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, Inc., a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer, today announced the pricing of its upsized initial public offering of 23,333,334 shares of common stock at a price to the public of $15.00 per share. The gross proceeds to Electra from the offering, before deducting underwriting discounts and co